Arcturus Therapeutics Holdings, Inc.

{
  "main_header": {
    "sid": 1150522,
    "name": "Arcturus Therapeutics Holdings, Inc.",
    "stock_name": "Arcturus Therapeutics Holdings, Inc.",
    "full_name": "Arcturus Therapeutics Holdings, Inc.",
    "name_url": "stocks-analysis/arcturus-therapeutics-holdings-inc",
    "exchange": 210,
    "exchangecode": "NAS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "7.02",
    "chg": -0.3,
    "chgp": "-4.1%",
    "dir": -1,
    "prev_price": "7.32",
    "mcapval": "197.41",
    "mcap": "Micro Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2305,
    "indexname": "S&P 500",
    "isin": "US03969T1097",
    "curr_date": "Feb 05",
    "curr_time": "",
    "bse_nse_vol": "989.16 k",
    "exc_status": "Active",
    "traded_date": "Feb 05, 2026",
    "traded_date_str": "2026 02 05",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/arcturus-therapeutics-holdings-inc-1150522-210&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Arcturus Therapeutics Hits 52-Week Low at $5.85 Amid Financial Struggles",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/arcturus-therapeutics-hits-52-week-low-at-585-amid-financial-struggles-3721526",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/ArcturusTherape_priceRelatedfactors_3721526.png",
        "date": "2025-11-21 15:56:04",
        "description": "Arcturus Therapeutics Holdings, Inc. has reached a new 52-week low, reflecting a difficult year marked by an 81.5% decline in stock price. The company faces ongoing financial challenges, including negative return on equity, a decrease in net sales, and significant losses in pre-tax profit, amidst a broader market contrast."
      },
      {
        "title": "Arcturus Therapeutics Hits 52-Week Low at $6.02 Amid Major Decline",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/arcturus-therapeutics-hits-52-week-low-at-602-amid-major-decline-3718640",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/ArcturusTherape_priceRelatedfactors_3718640.png",
        "date": "2025-11-20 16:38:12",
        "description": "Arcturus Therapeutics Holdings, Inc. has reached a new 52-week low, reflecting a challenging year marked by an 81.06% decline in stock price. The company reported a decrease in net sales and a negative pre-tax profit, alongside ongoing financial difficulties indicated by negative return on equity and EBITDA."
      },
      {
        "title": "Arcturus Therapeutics Hits 52-Week Low at $6.72 Amid Ongoing Struggles",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/arcturus-therapeutics-hits-52-week-low-at-672-amid-ongoing-struggles-3712540",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/ArcturusTherape_priceRelatedfactors_3712540.png",
        "date": "2025-11-18 17:04:01",
        "description": "Arcturus Therapeutics Holdings, Inc. has hit a new 52-week low, reflecting significant challenges in its financial performance. The company has seen a substantial decline in stock price over the past year, with negative returns on equity and disappointing quarterly results, raising concerns about its future viability."
      },
      {
        "title": "Arcturus Therapeutics Hits 52-Week Low at $7.26 Amid Financial Struggles",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/arcturus-therapeutics-hits-52-week-low-at-726-amid-financial-struggles-3707956",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/ArcturusTherape_priceRelatedfactors_3707956.png",
        "date": "2025-11-17 16:46:02",
        "description": "Arcturus Therapeutics Holdings, Inc. has reached a new 52-week low, reflecting a challenging year with a significant stock price decline. The company reported a decrease in net sales and consecutive negative quarterly results, alongside a low return on equity, as it faces ongoing financial difficulties."
      },
      {
        "title": "Arcturus Therapeutics Hits New 52-Week Low at $7.76",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/arcturus-therapeutics-hits-new-52-week-low-at-776-3702009",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/ArcturusTherape_priceRelatedfactors_3702009.png",
        "date": "2025-11-14 16:00:38",
        "description": "Arcturus Therapeutics Holdings, Inc. has reached a new 52-week low, reflecting a difficult year with a significant stock price decline. The company faces ongoing financial challenges, including negative return on equity and a decrease in net sales, while its market capitalization stands at USD 484 million."
      },
      {
        "title": "Arcturus Therapeutics Hits 52-Week Low at $7.93 Amid Financial Struggles",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/arcturus-therapeutics-hits-52-week-low-at-793-amid-financial-struggles-3686493",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/ArcturusTherape_priceRelatedfactors_3686493.png",
        "date": "2025-11-10 17:23:48",
        "description": "Arcturus Therapeutics Holdings, Inc. has reached a new 52-week low, reflecting a significant decline in its stock price over the past year. The company faces ongoing financial challenges, including negative return on equity, a high debt-to-equity ratio, and declining net sales, contributing to its underperformance in the market."
      }
    ],
    "total": 20,
    "sid": "1150522",
    "stock_news_url": "https://www.marketsmojo.com/news/arcturus-therapeutics-holdings-inc-1150522"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

Arcturus Therapeutics Hits 52-Week Low at $5.85 Amid Financial Struggles

2025-11-21 15:56:04

Arcturus Therapeutics Holdings, Inc. has reached a new 52-week low, reflecting a difficult year marked by an 81.5% decline in stock price. The company faces ongoing financial challenges, including negative return on equity, a decrease in net sales, and significant losses in pre-tax profit, amidst a broader market contrast.

Read full news article

Arcturus Therapeutics Hits 52-Week Low at $6.02 Amid Major Decline

2025-11-20 16:38:12

Arcturus Therapeutics Holdings, Inc. has reached a new 52-week low, reflecting a challenging year marked by an 81.06% decline in stock price. The company reported a decrease in net sales and a negative pre-tax profit, alongside ongoing financial difficulties indicated by negative return on equity and EBITDA.

Read full news article

Arcturus Therapeutics Hits 52-Week Low at $6.72 Amid Ongoing Struggles

2025-11-18 17:04:01

Arcturus Therapeutics Holdings, Inc. has hit a new 52-week low, reflecting significant challenges in its financial performance. The company has seen a substantial decline in stock price over the past year, with negative returns on equity and disappointing quarterly results, raising concerns about its future viability.

Read full news article

Arcturus Therapeutics Hits 52-Week Low at $7.26 Amid Financial Struggles

2025-11-17 16:46:02

Arcturus Therapeutics Holdings, Inc. has reached a new 52-week low, reflecting a challenging year with a significant stock price decline. The company reported a decrease in net sales and consecutive negative quarterly results, alongside a low return on equity, as it faces ongoing financial difficulties.

Read full news article

Arcturus Therapeutics Hits New 52-Week Low at $7.76

2025-11-14 16:00:38

Arcturus Therapeutics Holdings, Inc. has reached a new 52-week low, reflecting a difficult year with a significant stock price decline. The company faces ongoing financial challenges, including negative return on equity and a decrease in net sales, while its market capitalization stands at USD 484 million.

Read full news article

Arcturus Therapeutics Hits 52-Week Low at $7.93 Amid Financial Struggles

2025-11-10 17:23:48

Arcturus Therapeutics Holdings, Inc. has reached a new 52-week low, reflecting a significant decline in its stock price over the past year. The company faces ongoing financial challenges, including negative return on equity, a high debt-to-equity ratio, and declining net sales, contributing to its underperformance in the market.

Read full news article

View All News